High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells

Edmund Cheung So, Yi Ching Lo, Li Tzong Chen, Chin An Kao, Sheng Nan Wu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Triptolide (Trip), a diterpene triepoxide isolated from medicinal vine Trypterygium wilfordii Hook. F. possessed multiple biological activities including antineoplastic actions. However, no report concerning its effects on ion currents has been published. In this study, we attempted to determine whether this compound has any effects on ion currents in malignant glioma cells. The mRNA expression of KCNJ10 (Kir4.1) was detected in U373 glioma cells. The inwardly rectifying K+ currents (IK(IR)) in U373 cells were almost fully blocked by BaCl2 (1 mM). Trip (30 nM-10 μM) effectively decreased the amplitude of IK(IR) in a concentration-dependent manner with an IC50 value of 0.72 μM. In chlorotoxin-treated U373 cells, Trip-mediated block of IK(IR) remained effective. Addition of Trip (3 μM) slightly inhibited the amplitude of Ca2+-activated K+ current and sustained K+ outward current in U373 cells. In cell-attached configuration, when Trip was added to the bath, the activity of inwardly rectifying K+ (Kir) channels diminished with no change in single-channel conductance. Its suppression of Kir channels was accompanied by a reduction in the slow component of mean open time. Under current-clamp conditions, addition of Trip depolarized the membrane along with changes in frequency histogram of resting potential. Block by this component of Kir4.1 channels may be an important mechanism underlying its actions on the functional activity of glioma cells. Targeting at Kir4.1 channels may be clinically useful as an adjunctive regimen to anti-cancer drugs.

Original languageEnglish
Pages (from-to)332-341
Number of pages10
JournalEuropean Journal of Pharmacology
Volume738
DOIs
Publication statusPublished - 2014 Sep 5

Fingerprint

Diterpenes
Glioma
Ions
Inwardly Rectifying Potassium Channel
triptolide
Baths
Antineoplastic Agents
Membrane Potentials
Inhibitory Concentration 50
Messenger RNA
Membranes
Pharmaceutical Preparations
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{29252faeee544881b90077c0efa11d5a,
title = "High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells",
abstract = "Triptolide (Trip), a diterpene triepoxide isolated from medicinal vine Trypterygium wilfordii Hook. F. possessed multiple biological activities including antineoplastic actions. However, no report concerning its effects on ion currents has been published. In this study, we attempted to determine whether this compound has any effects on ion currents in malignant glioma cells. The mRNA expression of KCNJ10 (Kir4.1) was detected in U373 glioma cells. The inwardly rectifying K+ currents (IK(IR)) in U373 cells were almost fully blocked by BaCl2 (1 mM). Trip (30 nM-10 μM) effectively decreased the amplitude of IK(IR) in a concentration-dependent manner with an IC50 value of 0.72 μM. In chlorotoxin-treated U373 cells, Trip-mediated block of IK(IR) remained effective. Addition of Trip (3 μM) slightly inhibited the amplitude of Ca2+-activated K+ current and sustained K+ outward current in U373 cells. In cell-attached configuration, when Trip was added to the bath, the activity of inwardly rectifying K+ (Kir) channels diminished with no change in single-channel conductance. Its suppression of Kir channels was accompanied by a reduction in the slow component of mean open time. Under current-clamp conditions, addition of Trip depolarized the membrane along with changes in frequency histogram of resting potential. Block by this component of Kir4.1 channels may be an important mechanism underlying its actions on the functional activity of glioma cells. Targeting at Kir4.1 channels may be clinically useful as an adjunctive regimen to anti-cancer drugs.",
author = "{Cheung So}, Edmund and Lo, {Yi Ching} and Chen, {Li Tzong} and Kao, {Chin An} and Wu, {Sheng Nan}",
year = "2014",
month = "9",
day = "5",
doi = "10.1016/j.ejphar.2014.05.059",
language = "English",
volume = "738",
pages = "332--341",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells. / Cheung So, Edmund; Lo, Yi Ching; Chen, Li Tzong; Kao, Chin An; Wu, Sheng Nan.

In: European Journal of Pharmacology, Vol. 738, 05.09.2014, p. 332-341.

Research output: Contribution to journalArticle

TY - JOUR

T1 - High effectiveness of triptolide, an active diterpenoid triepoxide, in suppressing Kir-channel currents from human glioma cells

AU - Cheung So, Edmund

AU - Lo, Yi Ching

AU - Chen, Li Tzong

AU - Kao, Chin An

AU - Wu, Sheng Nan

PY - 2014/9/5

Y1 - 2014/9/5

N2 - Triptolide (Trip), a diterpene triepoxide isolated from medicinal vine Trypterygium wilfordii Hook. F. possessed multiple biological activities including antineoplastic actions. However, no report concerning its effects on ion currents has been published. In this study, we attempted to determine whether this compound has any effects on ion currents in malignant glioma cells. The mRNA expression of KCNJ10 (Kir4.1) was detected in U373 glioma cells. The inwardly rectifying K+ currents (IK(IR)) in U373 cells were almost fully blocked by BaCl2 (1 mM). Trip (30 nM-10 μM) effectively decreased the amplitude of IK(IR) in a concentration-dependent manner with an IC50 value of 0.72 μM. In chlorotoxin-treated U373 cells, Trip-mediated block of IK(IR) remained effective. Addition of Trip (3 μM) slightly inhibited the amplitude of Ca2+-activated K+ current and sustained K+ outward current in U373 cells. In cell-attached configuration, when Trip was added to the bath, the activity of inwardly rectifying K+ (Kir) channels diminished with no change in single-channel conductance. Its suppression of Kir channels was accompanied by a reduction in the slow component of mean open time. Under current-clamp conditions, addition of Trip depolarized the membrane along with changes in frequency histogram of resting potential. Block by this component of Kir4.1 channels may be an important mechanism underlying its actions on the functional activity of glioma cells. Targeting at Kir4.1 channels may be clinically useful as an adjunctive regimen to anti-cancer drugs.

AB - Triptolide (Trip), a diterpene triepoxide isolated from medicinal vine Trypterygium wilfordii Hook. F. possessed multiple biological activities including antineoplastic actions. However, no report concerning its effects on ion currents has been published. In this study, we attempted to determine whether this compound has any effects on ion currents in malignant glioma cells. The mRNA expression of KCNJ10 (Kir4.1) was detected in U373 glioma cells. The inwardly rectifying K+ currents (IK(IR)) in U373 cells were almost fully blocked by BaCl2 (1 mM). Trip (30 nM-10 μM) effectively decreased the amplitude of IK(IR) in a concentration-dependent manner with an IC50 value of 0.72 μM. In chlorotoxin-treated U373 cells, Trip-mediated block of IK(IR) remained effective. Addition of Trip (3 μM) slightly inhibited the amplitude of Ca2+-activated K+ current and sustained K+ outward current in U373 cells. In cell-attached configuration, when Trip was added to the bath, the activity of inwardly rectifying K+ (Kir) channels diminished with no change in single-channel conductance. Its suppression of Kir channels was accompanied by a reduction in the slow component of mean open time. Under current-clamp conditions, addition of Trip depolarized the membrane along with changes in frequency histogram of resting potential. Block by this component of Kir4.1 channels may be an important mechanism underlying its actions on the functional activity of glioma cells. Targeting at Kir4.1 channels may be clinically useful as an adjunctive regimen to anti-cancer drugs.

UR - http://www.scopus.com/inward/record.url?scp=84927171769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927171769&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2014.05.059

DO - 10.1016/j.ejphar.2014.05.059

M3 - Article

C2 - 24927992

AN - SCOPUS:84927171769

VL - 738

SP - 332

EP - 341

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -